Kaho Shionoya

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment

Hirofumi Ohashi, Koichi Watashi, Wakana Saso et al. · iScience · 2021 · 180 citations · Full text

Multidrug treatment with nelfinavir and cepharanthine against COVID-19

Hirofumi Ohashi, Koichi Watashi, Wakana Saso et al. · 2020 · 83 citations

Immunology, Immunotherapeutics, Antiviral Drug +17

Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro

Kaho Shionoya, Masako Yamasaki, Shoya Iwanami et al. · Frontiers in Microbiology · 2021 · 59 citations · Full text

Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2

Hirofumi Ohashi, Takayuki Hishiki, Daisuke Akazawa et al. · Antiviral Research · 2022 · 33 citations · Full text

Vaccination, Immunology, Antiviral Drug Development +11

Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as Treatments

Daisuke Akazawa, Hirofumi Ohashi, Takayuki Hishiki et al. · The Journal of Infectious Diseases · 2023 · 25 citations · Full text